Protocol No
ECOG-EA4151
Phase
III
Summary
To determine whether an autotransplant improves survival in MCL patients who have achieved an excellent (MRD-negative) first complete remission (CR).
Description
Rituximab with or without SCT in Treating Pt with MRD-Neg MCL in First Complete Remission
Participating Institutions
Froedtert Hospital
Moorland Reserve Health Center
Status
OPEN TO ACCRUAL
Categories
ClinicalTrials.gov